当前位置:首页 - 行情中心 - 药石科技(300725) - 财务分析 - 现金流量表

药石科技

(300725)

  

流通市值:51.87亿  总市值:61.48亿
流通股本:1.68亿   总股本:2.00亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金441,149,884.871,719,504,072.291,125,316,943.35743,915,474.91
收到的税费返还9,329,340.3277,113,442.7474,959,106.5361,295,212.25
收到其他与经营活动有关的现金14,284,003.8970,978,957.4657,909,216.3941,943,911.94
经营活动现金流入的平衡项目0000
经营活动现金流入小计464,763,229.081,867,596,472.491,258,185,266.27847,154,599.1
购买商品、接受劳务支付的现金176,413,743.78872,338,137.25545,157,525.11357,597,224.42
支付给职工以及为职工支付的现金183,118,750.51596,267,498.45453,586,156.79315,810,872.52
支付的各项税费24,362,259.7353,031,335.242,450,115.9225,402,069.96
支付其他与经营活动有关的现金25,538,217.3399,119,524.7968,421,400.3834,706,923.17
经营活动现金流出的平衡项目0000
经营活动现金流出小计409,432,971.351,620,756,495.691,109,615,198.2733,517,090.07
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额55,330,257.73246,839,976.8148,570,068.07113,637,509.03
二、投资活动产生的现金流量:
收回投资收到的现金473,102,663.633,236,399,332.821,523,529,537.95568,529,536.99
取得投资收益收到的现金5,558,543.8127,865,080.0120,910,088.1518,065,610.87
处置固定资产、无形资产和其他长期资产收回的现金净额-2,103,182.04770,535.15240,004.17
投资活动现金流入的平衡项目0000
投资活动现金流入小计478,661,207.443,266,367,594.871,545,210,161.25586,835,152.03
购建固定资产、无形资产和其他长期资产支付的现金18,739,063.71315,774,703.86294,795,319.03209,663,657.6
投资支付的现金380,000,0003,862,898,987.261,703,500,000672,000,000
支付其他与投资活动有关的现金10,992,10031,476,640.05--
投资活动现金流出的平衡项目0000
投资活动现金流出小计409,731,163.714,210,150,331.171,998,295,319.03881,663,657.6
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额68,930,043.73-943,782,736.3-453,085,157.78-294,828,505.57
三、筹资活动产生的现金流量:
取得借款收到的现金9,904.75466,482,500516,722,200387,034,500
筹资活动现金流入平衡项目0000
筹资活动现金流入小计9,904.75466,482,500516,722,200387,034,500
偿还债务支付的现金182,400,000337,571,846.76271,306,046.76175,128,552.11
分配股利、利润或偿付利息支付的现金3,697,660.2441,692,572.4237,253,349.832,287,807.56
支付其他与筹资活动有关的现金10,008,981.4421,847,490.671,824,363.58841,740.1
筹资活动现金流出平衡项目0000
筹资活动现金流出小计196,106,641.68401,111,909.85310,383,760.14208,258,099.77
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-196,096,736.9365,370,590.15206,338,439.86178,776,400.23
四、汇率变动对现金及现金等价物的影响3,663,004.51,893,497.4614,189,743.226,133,772.84
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-68,173,430.97-629,678,671.89-83,986,906.6523,719,176.53
加:期初现金及现金等价物余额508,271,709.141,137,950,381.031,137,950,381.031,137,950,381.03
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额440,098,278.17508,271,709.141,053,963,474.381,161,669,557.56
补充资料:
净利润-197,360,933.3-113,890,984.86
资产减值准备-47,668,721.83-23,138,945.93
固定资产和投资性房地产折旧-109,128,308.52-52,266,615.49
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-109,128,308.52-52,266,615.49
无形资产摊销-5,168,202.02-2,507,031.2
长期待摊费用摊销-5,494,832.45-2,761,480.53
处置固定资产、无形资产和其他长期资产的损失--416,669.74--
固定资产报废损失-3,418,575.37-170,678.58
公允价值变动损失-21,326,089.05-41,579,248.22
财务费用-65,636,660.01-9,545,324.74
投资损失--11,353,439.98--16,981,528.91
递延所得税-1,349,189.4--6,426,901.15
其中:递延所得税资产减少--2,811,044.35--5,521,767.13
递延所得税负债增加-4,160,233.75--905,134.02
存货的减少--74,735,813.98--81,364,991.56
经营性应收项目的减少-37,373,567.36--54,509,469.95
经营性应付项目的增加--177,783,266.85-13,882,853.86
其他-15,414,316.3-12,287,938.09
现金的期末余额-508,271,709.14-1,161,669,557.56
减:现金的期初余额-1,137,950,381.03-1,137,950,381.03
公告日期2024-04-242024-04-242023-10-312023-08-15
审计意见(境内)标准无保留意见
TOP↑